Eric Adams
Vermögen: 3 449 $ am 31.05.2026
Vermögen: 3 449 $ am 31.05.2026
Eric A. Adams is President, Chief Executive Officer & Director at InMed Pharmaceuticals, Inc. since 2016.
Formerly, Mr. Adams was Chief Executive Officer at Ronin8 Technologies Ltd. from 2014 to 2015, Director-Oncology Marketing at QLT, Inc. from 1998 to 2002, Non-Executive Director at enGene, Inc. from 2011 to 2013, Senior Manager-Business Development at Abbott Laboratories from 1992 to 1996, and Country Manager at Fresenius SE & Co. KGaA from 1988 to 1992.
Education includes graduate studies at the University of South Carolina and undergraduate studies at the University of Southern Indiana.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.12.2025 | 2 197 ( 0,07 % ) | 3 449 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Vorstandsvorsitzender | 16.06.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Vorstandsvorsitzender | 01.02.2015 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Vorstandsvorsitzender | 01.07.2013 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Vertrieb & Marketing | 01.12.2002 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.08.1996 |
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01.06.1992 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Industrial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen